JBRA assisted reproduction · 2026
Short Communication: Conflicting Conclusions in PGT-A: Live Birth Rates per Initiated Cycle or Oocyte Retrieval Show No Benefit, but Significant Improvement per Embryo Transfer.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pasotti Isabela M, Petersen Claudia, Vagnini Laura D, Massaro Fabiana C, Petersen Bruna, Nicoletti Andreia, Ricci Juliana, Zamara Camila, Pouza Renata A, Matuella Bianca C, Espirito-Santo Elisangela V, Meziara Joao B, Oliani Antonio H, Oliveira Joao Batista A, Franco Jose G
Аннотация
OBJECTIVE: To determine whether studies evaluating preimplantation genetic testing for aneuploidy (PGT-A) reach different conclusions depending on the denominator used to calculate live birth rates.
METHODS: A systematic review of studies published be-tween 2017 and 2025 was conducted using PubMed, Sco-pus, and Google Scholar. Randomized and non-randomized studies comparing IVF/ICSI cycles with and without PGT-A were included. Outcomes were analyzed per initiated cy-cle, oocyte retrieval, or embryo transfer. Relative risks were calculated using a random-effects model.
RESULTS: Eleven studies were included. No significant difference was observed when live birth rates were ana-lyzed per initiated cycle or oocyte retrieval (RR 1.04, 95% CI 0.91-1.18). However, PGT-A significantly improved live birth rates when analyzed per embryo transfer (RR 1.21, 95% CI 1.05-1.40).
CONCLUSION: The apparent benefit of PGT-A depends on the denominator used. Reporting outcomes per embryo transfer introduces selection bias and overestimates treat-ment effectiveness. Clinically meaningful outcomes should be reported per initiated cycle or oocyte retrieval.
METHODS: A systematic review of studies published be-tween 2017 and 2025 was conducted using PubMed, Sco-pus, and Google Scholar. Randomized and non-randomized studies comparing IVF/ICSI cycles with and without PGT-A were included. Outcomes were analyzed per initiated cy-cle, oocyte retrieval, or embryo transfer. Relative risks were calculated using a random-effects model.
RESULTS: Eleven studies were included. No significant difference was observed when live birth rates were ana-lyzed per initiated cycle or oocyte retrieval (RR 1.04, 95% CI 0.91-1.18). However, PGT-A significantly improved live birth rates when analyzed per embryo transfer (RR 1.21, 95% CI 1.05-1.40).
CONCLUSION: The apparent benefit of PGT-A depends on the denominator used. Reporting outcomes per embryo transfer introduces selection bias and overestimates treat-ment effectiveness. Clinically meaningful outcomes should be reported per initiated cycle or oocyte retrieval.